GB1309692A
(en)
*
|
1970-02-13 |
1973-03-14 |
Ucb Sa |
N-substituted lactams
|
US4081456A
(en)
*
|
1973-02-28 |
1978-03-28 |
Mobil Oil Corporation |
Bis-lactam derivatives
|
IT1045043B
(it)
*
|
1975-08-13 |
1980-04-21 |
Isf Spa |
Derivati pirrolidinici
|
AT360980B
(de)
*
|
1976-01-14 |
1981-02-10 |
Pliva Pharm & Chem Works |
Verfahren zur herstellung von n-alkylamiden des 2-oxo-1-pyrrolidins
|
US4069336A
(en)
*
|
1976-02-25 |
1978-01-17 |
Chemisches Laboratorium Fritz-Walter Lange Gmbh & Co Kg |
(2-oxo-pyrrolidines)-acetic hydrazides
|
GB1583871A
(en)
|
1976-10-19 |
1981-02-04 |
Ucb Sa |
Anti-aggregants
|
GB1539817A
(en)
*
|
1976-10-22 |
1979-02-07 |
Ucb Sa |
N-substituted lactams
|
GB1582351A
(en)
*
|
1977-02-10 |
1981-01-07 |
Ucb Sa |
Disubstituted ureas and thioureas
|
DE2757680A1
(de)
*
|
1977-12-23 |
1979-06-28 |
Troponwerke Gmbh & Co Kg |
Neue 2-oxo-1-pyrrolidinessigsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
CA1115212A
(en)
|
1978-02-10 |
1981-12-29 |
Emilio Kyburz |
Pyrrolidine derivatives
|
EP0005689B1
(fr)
|
1978-05-08 |
1981-03-18 |
U C B, S.A. |
Nouveaux acides lactame-N-acétiques et leurs amides, leurs procédés de préparation et compositions thérapeutiques
|
DE2924011C2
(de)
|
1979-06-13 |
1982-04-08 |
A. Nattermann & Cie GmbH, 5000 Köln |
Pyrrolidin-(2)-on-(1)-ylessigsäure-2,6,-dimethylanilid, Verfahren zur Herstellung und Arzneimittel, welche diese Verbindung enthalten
|
IT1141287B
(it)
*
|
1979-06-13 |
1986-10-01 |
Nattermann A & Cie |
Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
|
FR2515179A1
(fr)
*
|
1981-07-24 |
1983-04-29 |
Hoffmann La Roche |
Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
|
EP0089900B1
(en)
*
|
1982-03-24 |
1985-12-27 |
Prodes S.A. |
New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts
|
US4525476A
(en)
*
|
1983-05-26 |
1985-06-25 |
Warner-Lambert Company |
N-[1-oxo-3-(5-oxo-2-pyrrolidinyl)propyl]-alpha-aminoacids and derivatives as cognition activators
|
DE3326724A1
(de)
*
|
1983-07-25 |
1985-02-07 |
Boehringer Ingelheim KG, 6507 Ingelheim |
In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
|
DE3336024A1
(de)
*
|
1983-10-04 |
1985-04-18 |
Boehringer Ingelheim KG, 6507 Ingelheim |
4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
|
DE3420193A1
(de)
*
|
1984-05-30 |
1985-12-05 |
Boehringer Ingelheim KG, 6507 Ingelheim |
Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
|
FI83510C
(fi)
*
|
1985-02-22 |
1991-07-25 |
Ciba Geigy Ag |
Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara bi-2h- pyrroli(di)ndioner.
|
PH23078A
(en)
*
|
1986-01-30 |
1989-04-10 |
Ciba Geigy Ag |
Substituted pyrrolidinones
|
IT1224168B
(it)
*
|
1986-08-01 |
1990-09-26 |
Finanziaria R F Spa Ora Finanz |
Derivati del pirrolidin-2-one ad attivita' nootropa
|
US4990513A
(en)
*
|
1987-02-06 |
1991-02-05 |
S O "Pharmachim" |
Antihypoxic drug and method of its application
|
WO1988009330A1
(en)
*
|
1987-05-20 |
1988-12-01 |
Zambon Group S.P.A. |
Isoxazoles with nootropic activity
|
JPS6422883A
(en)
*
|
1987-07-17 |
1989-01-25 |
Sanwa Kagaku Kenkyusho Co |
1-pyrrolidine acetamide derivative, its salt, production thereof and prophylactic and remedial agent for cereral dysfunction containing said derivative and salt as active ingredient
|
JP2660201B2
(ja)
*
|
1988-08-05 |
1997-10-08 |
塩野義製薬株式会社 |
新規ピロロ[1,4]ベンゾジアゼピン誘導体および老人性痴呆薬
|
NO179903C
(no)
*
|
1992-06-19 |
1997-01-08 |
Daiichi Seiyaku Co |
Fremgangsmåte for fremstilling av et halogenacetamidderivat samt et pyrrolidinylacetamidderivat
|
CN1041630C
(zh)
*
|
1994-01-13 |
1999-01-13 |
北京大学 |
合成α-吡咯烷酮乙酰胺的方法
|
US5912189A
(en)
*
|
1998-05-12 |
1999-06-15 |
The Lubrizol Corporation |
Compositions containing reaction product of a cyclic compound containing both a nitrogen atom and a carbonyl group, an aldehyde or ketone, and an etheramine
|
GB0004297D0
(en)
*
|
2000-02-23 |
2000-04-12 |
Ucb Sa |
2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
|
JPWO2002053153A1
(ja)
*
|
2000-12-28 |
2004-04-30 |
第一製薬株式会社 |
神経因性疼痛治療及び予防薬
|
AU2009219050B2
(en)
|
2008-02-29 |
2014-04-24 |
Biolab Sanus Farmaceutica Ltda. |
Pharmaceutical composition comprising racetam and carnitine and process for its preparation
|
DK2346500T3
(en)
|
2008-10-16 |
2017-07-17 |
Univ Johns Hopkins |
Methods and compositions for improving cognitive function
|
PL389364A1
(pl)
|
2009-10-23 |
2011-04-26 |
Uniwersytet Jagielloński |
Nowe zastosowanie pochodnych 2-pirolidonu
|
EA202092673A3
(ru)
|
2010-02-09 |
2021-05-31 |
Дзе Джонс Хопкинс Юниверсити |
Способы и композиции для улучшения когнитивной функции
|
US10154988B2
(en)
|
2012-11-14 |
2018-12-18 |
The Johns Hopkins University |
Methods and compositions for treating schizophrenia
|
CN105142623A
(zh)
|
2013-03-15 |
2015-12-09 |
艾吉因生物股份有限公司 |
用于改善认知功能的方法和组合物
|
EP2968237A4
(en)
|
2013-03-15 |
2016-08-31 |
Univ Johns Hopkins |
METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
|
ME03518B
(me)
|
2014-01-21 |
2020-04-20 |
Janssen Pharmaceutica Nv |
Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
|
PL3096790T3
(pl)
|
2014-01-21 |
2020-01-31 |
Janssen Pharmaceutica, N.V. |
Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie
|
US11213517B2
(en)
|
2016-12-16 |
2022-01-04 |
Idorsia Pharmaceuticals Ltd |
Pharmaceutical combination comprising a T-type calcium channel blocker
|
EA037205B1
(ru)
*
|
2019-05-20 |
2021-02-19 |
Дмитрий Сергеевич Валуев |
Способ получения 2-(2-оксопирролидин-1-ил)-n-фенилацетамида
|
US20240132513A1
(en)
|
2022-08-19 |
2024-04-25 |
Agenebio, Inc. |
Benzazepine derivatives, compositions, and methods for treating cognitive impairment
|